Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

Conditions:		Head and Neck Cancer - Lung Cancer - Lip Cancer - Lip Neoplasms - Head and Neck Cancers
Purpose:		To correlate tumor oxygenation as measured by the Eppendorf electrode with the serum level of secreted proteins known to be induced by tumor hypoxia.
Study Summary:		The endpoints of the study are 1. To validate the prognostic significance of OPN in H&N and lung cancer patients and to monitor its level during active therapy and follow up for cancer surveillance. 2. To identify a gene and protein signature for hypoxia in H&N and lung cancer patients.
Criteria:		Inclusion Criteria:Newly diagnosed patients with head and neck cancer who has tumor accessible to tumor oxygenation measurement with a microelectrode.
NCT ID:		NCT00568490
Primary Contact:		Principal Investigator Quynh-Thu Le Stanford University Brindhath Bavan Phone: (650) 725-4777 Email: brindhas@stanford.edu
Backup Contact:		N/A
Location Contact:		Stanford, California 94305 United States Brindhath Bavan Phone: 650-725-4777 Email: brindhas@stanford.edu Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		May 18, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.